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Abstract
ZEBRA is a site-specific DNA binding protein that functions as a transcriptional activator and as an origin binding protein.
Both activities require that ZEBRA recognizes DNA motifs that are scattered along the viral genome. The mechanism by
which ZEBRA discriminates between the origin of lytic replication and promoters of EBV early genes is not well understood.
We explored the hypothesis that activation of replication requires stronger association between ZEBRA and DNA than does
transcription. A ZEBRA mutant, Z(S173A), at a phosphorylation site and three point mutants in the DNA recognition domain
of ZEBRA, namely Z(Y180E), Z(R187K) and Z(K188A), were similarly deficient at activating lytic DNA replication and
expression of late gene expression but were competent to activate transcription of viral early lytic genes. These mutants all
exhibited reduced capacity to interact with DNA as assessed by EMSA, ChIP and an in vivo biotinylated DNA pull-down
assay. Over-expression of three virally encoded replication proteins, namely the primase (BSLF1), the single-stranded DNA-
binding protein (BALF2) and the DNA polymerase processivity factor (BMRF1), partially rescued the replication defect in
these mutants and enhanced ZEBRA’s interaction with oriLyt. The findings demonstrate a functional role of replication
proteins in stabilizing the association of ZEBRA with viral DNA. Enhanced binding of ZEBRA to oriLyt is crucial for lytic viral
DNA replication.
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Introduction
There are many gaps in our understanding of the process by
which the Epstein-Barr virus (EBV) lytic replication machinery
assemble on DNA sites present in the viral genome.
EBV encodes an essential bZIP protein known as ZEBRA (aka
Zta, Z and BZLF1) that functions as a transcription activator of
viral and cellular genes and as an origin binding protein during
lytic DNA replication. An EB viral genome that lacks the open
reading frame encoding ZEBRA, bzlf1, loses its ability to activate
lytic gene expression and DNA replication [1]. ZEBRA interacts
both with promoters and with origins of lytic replication through
DNA sequences known as ZEBRA response elements (ZREs) that
are common to both types of DNA regulatory regions [2,3,4]. It is
unknown how ZEBRA distinguishes between a replication site and
a transcription activation site. The mechanism by which ZEBRA
activates transcription relies on its capacity to bind DNA and to
form physical contact with a number of cellular proteins. ZEBRA
binds to a wide variety of ZREs located in target promoters. Some
of these response elements contain methylated CpG motifs to
which ZEBRA binds with high preference [5]. The protein also
forms stable transcriptional initiation complexes with basic
components of the transcription machinery such as TBP, TFIID,
and the transcription co-activator CBP [6,7,8]. Since ZEBRA
augments the histone acetyl transferase (HAT) activity of CBP,
interaction of ZEBRA with CBP increases promoter accessibility
[9].
Activation of viral DNA synthesis during the lytic phase of the
EBV life cycle is dependent on the capacity of ZEBRA to
efficiently recognize a large (,1 kb) complex intergenic region
that serves as the origin of replication. This region, known as
oriLyt, consists of essential and auxiliary segments [10]. The two
essential components of oriLyt, the upstream and downstream
elements, together constitute the minimal origin of DNA
replication [2,11,12]. The auxiliary component serves as an
enhancer element that augments DNA replication [13,14].
ZEBRA recognizes the origin of lytic DNA replication (oriLyt)
by interacting with seven ZEBRA-binding sites [12,15]. Mutation
of all seven binding motifs in the background of a recombinant
virus drastically reduces production of infectious virus particles
[16]. These ZEBRA binding elements are located in two non-
contiguous regions of oriLyt. Four elements are present in the
upstream core region of oriLyt and overlap with the promoter of
the BHLF1 open reading frame [3]. Knocking out any of these
four elements was deleterious for amplification of an oriLyt-
containing plasmid in a transient replication assay [17]. Three
additional ZEBRA binding elements located mainly in the
enhancer region are dispensable for viral replication [17].
PLoS Pathogens | www.plospathogens.org 1 August 2010 | Volume 6 | Issue 8 | e1001054The current model for the role of ZEBRA in lytic DNA replication
suggests that the protein serves as a physical link between oriLyt and
core components of the replication machinery [18,19]. The six core
replication factors encoded by EBV are the DNA polymerase
(BALF5); the polymerase processivity factor (BMRF1); the helicase
(BBLF4); the primase (BSLF1); the primase associated factor
(BBLF2/3), and the single-stranded DNA binding protein (BALF2)
[4]. Corroboration for the proposed role of ZEBRA in replication is
inferred from data showing that ZEBRA interacts with almost all
components of the viral replication machinery, with the exception of
the single-stranded DNA binding protein (BALF2) [18,20,21,22].
The function of tethering replication proteins to oriLyt is not limited
to ZEBRA; the transactivation domains of Sp1 and ZBP89 interact
with BMRF1 and BALF5 and target them to the downstream region
of oriLyt [18,23]. Similarly, ZBRK1, a cellular DNA binding zinc
finger protein, serves as a contact point for BBLF2/3 on oriLyt [19].
D e l e t i o no ft h eZ B R K 1b i n d i n gs i t ep r e s e n ti nt h ed o w n s t r e a m
region of oriLyt reduced oriLyt-dependent replication of a transiently
transfected plasmid. Binding of these cellular transcription factors is
not essential but contributes to replication efficiency.
ZEBRA mutants that activate transcription but not replication
are valuable in furthering our understanding of the process of EBV
lytic DNA replication. ZEBRA is phosphorylated in vivo at multiple
sites [24]. Phosphorylation of ZEBRA at S173 regulates lytic viral
replication [25]. Serine 173 is located in a region N-terminal to the
DNA binding domain of ZEBRA. This region, known as the
regulatory domain, regulates the DNA binding activity of the
protein [25,26,27]. Alanine substitution of the phosphoacceptor
site S173 reduced the capacity of ZEBRA to bind to DNA in vitro
and in vivo [25]. Attenuation in DNA binding correlated with a
defect in the capacity of ZEBRA to stimulate lytic viral replication.
However, it had no effect on the ability of ZEBRA to activate
transcription of downstream viral target genes. Thus phosphory-
lation of S173 segregates the two main functions of ZEBRA,
namely activation of transcription and activation of viral
replication. In addition, the S173A mutant demonstrates that
activation of transcription is not sufficient to stimulate viral
replication. Additional proof for the role of phosphorylation of
S173 in replication was attained when a phosphomimetic
substitution mutant Z(S173D) activated both transcription and
replication and was competent to bind DNA to the same extent as
wild-type (wt) ZEBRA. Therefore, phosphorylation of ZEBRA at
S173 functionally mimics ATP binding in other origin binding
proteins by enhancing the DNA binding activity of ZEBRA to all
ZREs in general and not to a specific site [25].
In a comprehensive mutagenesis study of the DNA binding
domain of ZEBRA we identified ZEBRA mutants that arrested
the EBV lytic cycle at different stages [28]. Two of these mutants,
Z(Y180E) and Z(K188A), caused lytic cycle arrest prior to viral
replication. They reproducibly activated expression of viral early
genes but were defective in inducing amplification of EBV DNA
and late gene expression [28]. These mutants did not affect the
phosphorylation site in the regulatory domain, S173, but changed
specific residues within the DNA recognition domain. The
availability of replication defective (RD) ZEBRA mutants
prompted us to investigate the effect of alterations in the DNA
binding activity of ZEBRA on viral replication. If replication is
indeed less tolerant than transcription for weak interaction
between ZEBRA and DNA, then stronger association with oriLyt
is necessary and might play a critical role in origin activation.
Augmentation of ZEBRA binding to oriLyt is likely to be mediated
by factors specific for viral replication. For example in budding
yeast, interaction of the ORC with Cdc6 enhances its interaction
with the origin of replication [29]. Here we describe a new role for
three components of the EBV replication complex, namely, the
primase, the single-stranded DNA binding protein and the DNA
processivity factor. We show that over-expression of these three
replication proteins is sufficient to increase the association of
ZEBRA with viral DNA. This augmentation in DNA binding
suppressed the phenotype of ZEBRA replication defective mutants
and partially restored viral genome amplification and late gene
expression. Our findings represent the first indication that three
replication proteins play a role in enhancing the interaction
between ZEBRA and viral DNA thereby promoting origin
recognition, a process that is exquisitely sensitive to the DNA
binding activity of ZEBRA.
Results
Characterization of ZEBRA replication defective (RD)
mutants
Previously we described three ZEBRA mutants which activated
expression of early genes but failed to activate viral replication and
late gene expression. The ZEBRA mutants that reproducibly
exhibited replication defective phenotype were: Z(S173A) in the
regulatory domain and Z(Y180E) and Z(K188A) in the DNA
recognition domain [25,28]. In further exploration of this
phenomenon we identified a fourth ZEBRA RD mutant with a
conservative arginine to lysine substitution at position 187. Fig. 1A,
C and D compare the phenotype of Z(R187K) to wt ZEBRA,
Z(K188A) and Z(F193E). Z(K188A) served as a typical ZEBRA
RD mutant; the mutant Z(F193E) was partially defective in
induction of late genes and DNA replication. Expression of
Z(R187K) in BZKO cells induced a pattern of lytic gene
expression that mimicked Z(K188A); it fully activated expression
of two early proteins, Rta and EA-D (aka BMRF1), encoded by
brlf1 and bmrf1, but failed to activate synthesis of two late proteins
BFRF3 (FR3) (a component of the viral capsid) and BLRF2 (LR2)
(a tegument protein) (Fig. 1A). Rta and EA-D are direct targets of
ZEBRA; their expression is governed by the ability of ZEBRA to
bind to their corresponding promoters, Rp and BMRF1p,
respectively [30,31,32]. Activation of expression of the two late
proteins, FR3 and LR2, is associated with the capacity of ZEBRA
to induce lytic viral replication [33].
Author Summary
Epstein-Barr virus encodes a protein, ZEBRA, which plays
an essential role in the switch between viral latency and
the viral lytic cycle. ZEBRA activates transcription of early
viral genes and also promotes lytic viral DNA replication. It
is not understood how these two functions are discrim-
inated. We studied five ZEBRA mutants that are impaired
in activation of replication but are wild-type in the capacity
to induce transcription of early viral genes. We demon-
strate that these five mutants are impaired in binding to
viral DNA regulatory sites. Therefore, replication required
stronger interactions between ZEBRA and viral DNA than
did transcription. Three components of the EBV-encoded
replication machinery, including the single-stranded DNA
binding protein, the polymerase processivity factor and
the primase markedly enhanced the interaction of ZEBRA
with viral DNA. These three components partially rescued
the defect in ZEBRA mutants that were impaired in
replication. The results suggest that through protein-
protein interaction, replication proteins play a role in
enhancing ZEBRA’s association with the origin of DNA
replication and other regulatory sites.
Origin Recognition during EBV Replication
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sole cause for the observed defect in late gene expression, the
mutant Z(Y180E) was reverted to its original amino acid
composition, i.e. tyrosine. As expected, Z(Y180E) was impaired
in activating late gene expression while the revertant mutant
Z(Y180ERY) was competent to activate late gene expression to
the same level as wt ZEBRA (Fig. 1B).
To examine whether the defect in late gene expression was due
to a failure in stimulating viral replication, we tested the capacity
of Z(R187K) to induce viral genome amplification by probing for
two different regions of viral DNA. First, we probed for a region
upstream of the viral terminal repeats (TRs). During lytic viral
replication linear viral genomes are synthesized. These linear
forms differ in their number of terminal repeats and are detected
on a Southern blot as a ladder [34]. In Fig. 1C, wt ZEBRA
induced the formation of a replication ladder. Z(F193E) was
slightly impaired and resulted in a less intense ladder than wt
ZEBRA. The two late mutants Z(R187K) and Z(K188A) failed to
induce the replication ladder. Comparable results were observed
when a Southern blot of a parallel experiment was probed for the
reiterated BamH1 W sub-fragment of EBV DNA (Fig. 1D). All the
RD mutants were defective at amplifying viral DNA when assessed
by qPCR (Fig. S3). Based on these results and our previous studies,
we conclude that RD mutants Z(S173A), Z(Y180E), Z(R187K),
and Z(K188A) are competent to activate expression of early viral
proteins but incompetent to activate lytic viral DNA replication
and late gene expression (see also Fig. S3).
ZEBRA RD mutants can activate transcription of the
endogenous brlf1 gene
Although the data in Fig. 1 showed that the four replication
defective mutants activated expression of two early proteins, Rta
and EA-D to the same level as wt ZEBRA, this result did not
directly assess the capacity of the mutants to activate transcription
Figure 1. ZEBRA mutants defective in lytic replication and late gene expression. (A) Z(R187K) and Z(K188A) fail to activate two late
proteins, FR3 and LR2. Immunoblot analysis of extracts prepared from BZKO cells transfected with expression vectors encoding wt ZEBRA (Z) and the
following ZEBRA mutants: Z(K188A), Z(F193E), and Z(R187K). The membrane was probed for the EBV gene products, Rta, EA-D (early antigen-diffuse,
the DNA polymerase processivity factor or BMRF1), ZEBRA, LR2 and FR3. NS, non specific. B) Z(Y180E), but not its revertant, specifically fails to activate
EBV late gene expression. An immunoblot of transfected BZKO cells was probed with antibodies as described in panel A. C) and D) Southern blots
assessing lytic viral DNA replication. Total DNA was extracted 48 hrs after transfection of the expression vectors. The DNA was digested with BamH1.
The blots were probed with either a 0.3 kb subfragment of the Xho 1.9 fragment (Fig. 1C) or the BamH1 W fragment (Fig. 1D). FT, fused termini of the
endogenous viral genome (v); Z(p), plasmid encoding ZEBRA; CMV, (p) empty plasmid; W(v), the BamW fragment of the endogenous virus (v).
doi:10.1371/journal.ppat.1001054.g001
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important since activation of the brlf1 promoter by direct binding
of ZEBRA is a crucial initial event in activation of the EBV lytic
cycle [5,30,31,32,35]. Therefore, using quantitative RT-PCR we
measured the level of endogenous brlf1 mRNA, encoding Rta, in
BZKO cells expressing each of the four ZEBRA RD mutants. We
found that wt ZEBRA induced expression of the brlf1 message by
776-fold relative to the background level of brlf1 mRNA detected
in cells transfected with empty vector (Fig. 2A). The level of brlf1
expression was corrected for the corresponding level of the gapdh
transcript measured in each sample (Fig. 2B). The ZEBRA RD
mutants, Z(S173A), Z(Y180E), Z(R187K) and Z(K188A), repro-
ducibly activated expression of the brlf1 message to levels similar or
higher than that of wt ZEBRA (Fig. 2, S4A and S5). Therefore,
despite a clear defect in the capacity of these ZEBRA mutants to
activate viral replication, the mutants were fully competent to
activate transcription of the early brlf1 gene.
The RD ZEBRA mutants activate transcription of EBV-
encoded replication genes
In addition to its role in replication, expression of ZEBRA leads
to activation of transcription of early lytic cycle genes, six of which
constitute core components of the viral lytic replication machinery
[4,36]. The defect observed with the ZEBRA RD mutants could
be attributed to failure to activate transcription of one or more
genes encoding essential replication proteins. To investigate this
possibility, we examined the capacity of the ZEBRA mutants to
activate transcription of the different components of the viral
replication machinery. Expression of balf2, the gene encoding the
single-stranded DNA binding protein was examined by expressing
five ZEBRA mutants in BZKO cells. Three of these mutants,
Z(Y180E), Z(K188A) and Z(R187K), are markedly defective in
activating late gene expression and viral replication, Fig. 1, Fig. S3
and [28]. The other two mutants, Z(F193E) and Z(K194A), are
slightly to moderately impaired in activating viral replication and
late gene expression (Fig. 1, [28] and unpublished data). 48 h after
transfection of BZKO cells, we compared the level of balf2
expression among the mutants using Northern blot analysis. All
five mutants activated the balf2 message to a level equivalent to wt
ZEBRA (Fig. 3A). As a positive control for migration of the balf2
transcript we used RNA from HH514-16 cells induced into the
lytic cycle with sodium butyrate.
Using quantitative RT-PCR we assessed the level of transcripts
encoding the heterotrimeric helicase-primase complex in cells
expressing five RD mutants: the regulatory mutants, Z(S173A) and
Z(S167A/S173A) and the three basic domain mutants, Z(Y180E),
Z(R187K) and Z(K188A). We employed two different methods to
prepare cDNA from purified RNA samples. In the experiment
illustrated in Fig. 3B and 3C, we synthesized cDNA using gene
specificprimersthatwerecomplementarytoviralhelicase(BBLF4)or
viral primase (BSLF1). In Fig. 3D, 3E and 3F, we used a mixture of
random hexamers and poly-dT to synthesize cDNA. It is important
to note that each of the DNA fragments amplified by RT PCR
acquired the same melting point and electrophoretic mobility on
agarose gels as DNA fragments amplified by PCR from an expression
vector containing a cloned version of the corresponding gene (data
not shown). To confirm that the purified RNA samples were not
contaminated with genomic DNA we omitted the reverse transcrip-
tase enzyme from the reaction mixture. As a result no DNA
amplification was detected (Fig. 3B).
Regardless of the method used for cDNA preparation, we found
that the levels of mRNAs for viral helicase, primase and primase-
associated factor (BBLF2/3) in cells expressing wt ZEBRA were
several fold higher than in cells transfected with empty vector. All
four RD mutants were competent to activate expression of the
viral helicase and primase to levels comparable or higher than
those activated by wt ZEBRA. The mutants, particularly the basic
domain mutants, activated twice as much helicase and primase
transcripts as the wild type protein. For example, Z(K188A)
activated between 2.3 to 2.6-fold more bblf4 mRNA than wt
ZEBRA (Fig. 3B and 3D).
Expression of BBLF2/3 is insufficient to suppress the
phenotype of the ZEBRA RD mutants
The primase-associated-factor (BBLF2/3) was the only gene
that exhibited lower transcript levels in cells expressing RD
mutants compared to those expressing wt ZEBRA (Fig. 3F).
However, the level of bblf2/3 mRNA was still 5–9-fold above
background. To determine whether ectopic expression of BBLF2/
3 could rescue the defect in these mutants, we co-expressed
BBLF2/3 with two ZEBRA RD mutants, Z(S173A) and
Z(Y180E), in BZKO cells. Forty-eight hours after transfection,
cells were harvested and analyzed for late gene expression and
viral replication. We found that over-expression of BBLF2/3 had
no effect on the level of the late protein, FR3, induced by wt
ZEBRA, Z(S173A) or Z(Y180E) (Fig. 4A). Similarly, using
quantitative PCR to determine the extent of viral genome
amplification, we found the same levels of viral genome in cells
expressing Z(S173A) or Z(Y180E) in the absence or presence of
BBLF2/3. The level of viral DNA present in cells transfected with
the mutants was approximately equal to that in control cells
transfected with empty vector (Fig. 4B). These experiments showed
that impairment of ZEBRA RD mutants to induce late gene
expression and viral replication was not the result of the slightly
reduced levels of the bblf2/3 transcript detected following
expression of this class of ZEBRA mutants. Moreover, over-
expression of BBLF2/3 protein could not rescue the late mutants.
ZEBRA RD mutants display weak DNA binding activity in
vitro
Previously, we showed that reduction in the DNA binding
activity of ZEBRA, due to alanine substitution of the phosphor-
ylation site S173, correlated with a defect in the capacity of
ZEBRA to induce viral replication. The same impairment of
binding was detected between Z(S173A) and the Rta promoter,
but Z(S173A) was competent to activate expression of Rta to the
same extent as wt ZEBRA [25]. This finding provoked the
hypothesis that the DNA binding affinity of ZEBRA was of
relatively greater importance for activation of viral replication than
for activation of transcription. To further investigate this
correlation we used an electrophoretic mobility shift assay (EMSA)
to assess the DNA binding activity of ZEBRA RD mutants located
in the basic domain of the protein. Fig. 5 compares the DNA
binding activity of Z(Y180E) and K(188A) with that of wt ZEBRA
and with Z(K188R), a mutant with a conservative change that
manifests a wild phenotype. An EMSA assay was performed using
cell extracts obtained from EBV negative HKB5/B5 cells
transfected with the indicated expression vectors. Four ZEBRA
response elements, ZIIIB and ZREs 1 to 3, were used as probes.
ZIIIB represents the highest affinity binding site for ZEBRA; it
mediates auto-stimulation of the ZEBRA promoter [37,38]. ZREs
1–3 represent a cluster of sites present in the upstream essential
region of oriLyt. Both Z(Y180E) and Z(K188A) were markedly
impaired in binding to each of the four probes relative to wt
ZEBRA. The efficiency of binding was calculated as the
percentage of probe shifted by each mutant protein. Z(Y180E)
shifted between 0.1% and 0.7% depending on the probe used in
Origin Recognition during EBV Replication
PLoS Pathogens | www.plospathogens.org 4 August 2010 | Volume 6 | Issue 8 | e1001054Figure 2. Replication defective ZEBRA mutants activate brlf1 gene expression to wild-type levels. Total RNA was purified from BZKO cells
48 hrs after transfection with vector, wt ZEBRA or the indicated replication defective ZEBRA mutants. Expression of the brlf1 (panel A) and the gapdh
(panel B) messages was measured by quantitative RT-PCR and normalized to the level of these transcripts in BZKO cells transfected with empty
vector. Fold expression of brlf1 mRNA was corrected for the amount of gapdh transcripts detected in the same sample.
doi:10.1371/journal.ppat.1001054.g002
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46% (Fig. 5A). The ZEBRA mutant, Z(K188R), which is fully
competent to activate the lytic cycle [28], shifted the same set of
ZEBRA specific DNA probes to percentages that were markedly
higher than those observed with the ZEBRA RD mutants, namely
12.3% and 38.8% of the total probe (Fig. 5A). These in vitro DNA
binding studies clearly indicated that Z(Y180E) and Z(K188A) are
both significantly impaired in their capacity to bind to ZEBRA
response elements present in regulatory sites for transcription or
replication. The differences in DNA binding between wt ZEBRA
and the mutants were not due to variable protein levels. Western
blot analysis with an antibody against ZEBRA demonstrated that
all EMSA extracts contained similar levels of ZEBRA protein
(Fig. 5B).
Figure 3. ZEBRA replication defective (RD) mutants are competent at activating expression of EBV genes encoding the viral lytic
replication machinery. A) Northern blot analysis of balf2 mRNA isolated from BZKO cells transfected with wild type BZLF1 and ZEBRA point
mutants. Cells were harvested after 48 h. RNA prepared from HH514-16 (cl16) cells treated with sodium butyrate was used as a positive control for
the expression of balf2 mRNA. RNaseP served as a control for the total amount of cellular RNA loaded on the gel. Panels B, C, D, E and F represent
quantitative RT-PCR to measure the expression level of the EBV helicase (bblf4) (Fig. 3B and D), the EBV primase (bslf1) (Fig. 3C and E) and the EBV
primase-associated factor (bblf2/3) (Fig. 3F), in cells transfected with CMV (empty vector) or expression vectors for wt ZEBRA or mutant ZEBRA
proteins. Fold expression for each transcript was calculated using the standard curve method and was corrected for the level of gapdh mRNA. In Figs.
3B and C, the reverse transcription reaction was performed using gene specific primers. In Fig. D, E and F, cDNA was synthesized using a mixture of
poly(dT) and random hexamer primers.
doi:10.1371/journal.ppat.1001054.g003
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To analyze the ability of the ZEBRA RD mutants to associate
with the viral origin of lytic replication (oriLyt) in vivo, we employed
chromatin immunoprecipitation (ChIP). To study the associations
of the three basic domain ZEBRA RD mutants with oriLyt we
transfected BZKO cells with expression vectors encoding each of
the ZEBRA RD mutants, wt ZEBRA and a non-DNA binding
form of ZEBRA, Z(R183E), which does not activate transcription
or replication. In this experiment, the wild type protein was the
only form of ZEBRA that was capable of inducing viral
replication. To compare the amount of oriLyt immunoprecipitat-
ed by each ZEBRA protein we maintained equivalent levels of
viral DNA by blocking viral replication with phosphonoacetic acid
(PAA). We found that all ZEBRA RD mutants were more efficient
than the non-DNA binding mutant Z(R183E), but less competent
than wt ZEBRA in precipitating the upstream region of oriLyt.
3.7-fold less oriLyt was immunoprecipitated from cells expressing
Z(Y180E) compared to those expressing wt ZEBRA (Fig. 6A).
Similarly, Z(R187K) and Z(K188A) pulled down 2.9 and 8.3-fold
less DNA than wt ZEBRA. The extent of association of each
mutant with oriLyt was corrected for the total amount of oriLyt
detected in the corresponding input sample. Fig. 6B shows that the
level of input oriLyt was approximately the same in cells
transfected with wild type and all three mutants. These results
suggest that amino acid changes introduced in the three ZEBRA
RD mutants did not completely abolish interaction of ZEBRA
with oriLyt as was observed with the non DNA binding mutation
R183E. Nonetheless, the ability of the RD mutants to bind to
oriLyt in cells was 3- to 8-fold impaired compared with wt
ZEBRA.
Figure 5. ZEBRA mutants that fail to activate viral replication are defective at binding DNA in vitro. A) Electrophoretic mobility shift
assay (EMSA) comparing the DNA binding activity of Z(Y180E), Z(K188A), Z(K188R) and wt ZEBRA using four ZEBRA response elements. ZREs 1-3 are
present in the origin of lytic replication (oriLyt), while ZIIIB is present in the bzlf1 promoter. The latter site has the highest affinity to ZEBRA among
other known ZREs and was used as a positive control for binding. Probes were shifted using HKB5/B5 cell extracts expressing different ZEBRA
proteins. B) Western blot analysis of the levels of wild-type ZEBRA or mutant ZEBRA present in cell extracts used for EMSA. The immunoblot was
probed with a polyclonal antibody against ZEBRA.
doi:10.1371/journal.ppat.1001054.g005
Figure 4. Over-expression of BBLF2/3 fails to complement the defect in ZEBRA mutants impaired in lytic viral replication and late
gene expression. A) Western blot analysis of BZKO cells expressing the indicated proteins. The membrane was incubated with antibodies against
BFRF3, ZEBRA and the myc tag. B) Real time PCR to detect the extent of viral genome amplification in BZKO cells transfected with the indicated
ZEBRA replication defective mutants in the absence or presence of BBLF2/3. The primers were specific for the EBV brlf1 promoter. The data shown
represent the average of three different experiments.
doi:10.1371/journal.ppat.1001054.g004
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in vivo. Chromatin immunoprecipitation of ZEBRA protein and its associated DNA. BZKO cells were transfected with expression vectors encoding wt
ZEBRA, a non-DNA binding mutant Z(R183E), and three replication defective ZEBRA mutants [Z(Y180E), Z(R187K) and Z(K188A)]. PAA was added to
block viral DNA replication. Cells were harvested 48 h after transfection. (A) The amount of precipitated oriLyt was measured by real time PCR using
the standard curve method. The bar graph represents the amount of oriLyt precipitated by a polyclonal ZEBRA antibody divided by the amount of
oriLyt detected in the corresponding input sample (panel B). The ChIP/Input value of each sample was normalized to that of wild type ZEBRA (Z). B)
Origin Recognition during EBV Replication
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interacting with Rp and with oriLyt
The Rta promoter (Rp) is a direct target for activation by
ZEBRA. In Fig. 1, 2, S4 and S5, we showed that all ZEBRA RD
mutants were fully competent to induce wild type levels of brlf1
(Rta) mRNA and protein. However, EMSA experiments showed
that the ZEBRA RD mutants were similarly defective in binding
to ZEBRA response elements regardless of their presence in
transcription or replication regulatory regions (Fig. 5 and [25]). To
investigate whether the ZEBRA RD mutants are impaired in their
capacity to associate with Rp, in a separate experiment we carried
out ChIP experiments to compare directly the capacity of two RD
mutants to precipitate oriLyt and Rp DNA relative to wt ZEBRA.
We found that Z(Y180E) and Z(K188A) were two-to three-fold
defective in interacting both with Rp and with oriLyt when
compared to the wild type protein (Fig. 6C and D). However, these
RD mutants displayed higher efficiency to interact with oriLyt and
Rp than the non-DNA binding ZEBRA mutant Z(R183E). The
Z(R183E) mutant pulled down amounts of oriLyt and Rp that
were equivalent to those detected in ChIP experiments performed
with cells transfected with empty vector or precipitated with pre-
immune serum (Fig. 6). The finding that RD mutants are equally
impaired in binding to Rp and oriLyt suggests that activation of
brlf1 transcription is more tolerant of weaker interaction between
ZEBRA and its response elements than is stimulation of
replication.
Assessing the association of ZEBRA with oriLyt and Rp
using an in vivo biotinylated DNA affinity assay (iBDAA)
The ChIP assay measures the amount of DNA associated with
ZEBRA, but does not measure how much ZEBRA interacts
with DNA. Therefore, we employed a different approach to
assay for the capacity of ZEBRA to bind DNA in cells (Fig. 7).
The assay relied on co-transfecting vectors encoding wild type
ZEBRA or ZEBRA mutants together with biotin-conjugated
probes. The BUR probe is 167 bp long and encompasses the
four ZREs in the upstream region of oriLyt that are crucial for
lytic replication. BRpS and BRpL represent short (156 bp) and
long (277 bp) segments of Rp. BRpS contains the ZIIIA site,
while the BRpL has all three identified ZREs present in Rp.
After 48 h, BZKO cells were harvested and biotinylated probes
were captured using avidin coated beads. The level of ZEBRA
protein bound to each probe was determined by western blot.
T h er e l a t i v eb i n d i n go fZ E B R At o each probe was corrected for
the total amount of ZEBRA protein present in each sample. In
cells transfected with ZEBRA RD mutants, all three biotinylated
probes pulled down less ZEBRA protein compared to cells
transfected with wt ZEBRA. The defect in binding relative to wt
ZEBRA averaged between 75% to 89% for the oriLyt probe
(Fig. 7A); 57% to 93% for the short Rp probe (Fig. 7B), and
66% to 95% for long Rp probe (Fig. 7C). Our results with the
transfected biotinylated probe assay confirm the EMSA and
ChIP experiments. These three different assays show that
replication defective mutants of ZEBRA are markedly impaired
in binding to DNA. This defect in DNA binding can be seen
with probes for oriLyt and Rp.
Expression of the six EBV replication proteins partially
restored the capacity of RD mutants to activate viral
replication and late gene expression
Our findings suggest that weak association of ZEBRA with
oriLyt has significant ramifications for subsequent events that lead
to lytic viral DNA replication. These events might involve a
specific protein-protein interaction between ZEBRA and one or
more of the replication proteins. In an attempt to restore this
interaction we over-expressed the six components of the EBV
replication machinery together with each of the ZEBRA RD
mutants in BZKO cells. Over-expression of replication proteins
partially rescued late gene expression by all four ZEBRA RD
mutants. The extent of rescue ranged between 3- to 4-fold
regardless of the level of late gene expression induced by each
mutant in the absence of replication proteins (Fig. 8A, C and D).
For example, in case of Z(S173A), expression of replication
proteins reproducibly increased FR3 expression by 3.2-fold
reaching 55% that of wt ZEBRA alone. This effect on late gene
expression was not an anomalous feature of these mutants; a
similar increase was detected with the wild type ZEBRA protein
and ranged between 1.6- and 2.5-fold (Fig. 8C and D). While
expression of the late FR3 protein can be used as an indirect
marker for viral replication, we also examined the effect of over-
expressing replication proteins on the capacity of wt ZEBRA and
ZEBRA RD mutants to induce viral genome amplification.
Expression of high levels of replication proteins reproducibly
augmented the capacity of wt ZEBRA and Z(S173A) to stimulate
EBV lytic replication by 1.9- and 3.4-fold respectively. In this
experiment no similar effect of the complete mixture of replication
proteins on DNA amplification was observed with the other
ZEBRA RD mutants (Fig. 8B). However, subsequent experiments
defined a subset of replication proteins that was capable of
rescuing replication by all the RD mutants (Fig. S3).
Expression of EBV replication proteins increased ZEBRA
association with oriLyt in vivo
In experiments illustrated in Figs. 5 to 7 and previously
published [25] we found a direct correlation between strong
association of ZEBRA with oriLyt and viral replication. To
explore the possibility that replication proteins enhance interaction
of ZEBRA with oriLyt, thereby partially restoring EBV lytic
replication, we carried out ChIP experiments combined with
quantitative PCR. In Fig. 9A, BZKO cells were transfected with
empty vector (CMV), Z(S173A) or wt ZEBRA in the presence and
absence of the six EBV replication proteins. In ChIP experiments,
we found that BZKO cells transfected with Z(S173A) or wt
ZEBRA yielded more oriLyt when replication proteins were co-
expressed, 1.58-fold and 1.72-fold, respectively (Fig. 9A). This
increase was independent of the level of ZEBRA expressed or
immunoprecipitated. Western blot analysis showed that similar
levels of ZEBRA protein were present in each immune-precipitate
(Fig. 9B). Expression of the six replication proteins had no effect on
the amount of oriLyt immunoprecipitated from cells transfected
with empty vector.
A biological replicate experiment was performed and included
two additional ZEBRA RD mutants, Z(Y180E) and Z(S167A/
S173A) [25]. Wild type and mutant ZEBRA were expressed in
Relative amount of oriLyt DNA either present in input samples or immunoprecipitated by pre-immune or anti ZEBRA antibody. (C) and (D)
Comparison of the association of ZEBRA replication defective mutants with Rp and oriLyt. Chromatin immunoprecipitation of ZEBRA protein from
BZKO cells expressing wt ZEBRA, Z(R183E), Z(Y180E) or Z(K188A) and treated with PAA. Quantitative PCR was performed using primers specific to Rp
(C) and to oriLyt (D). The amount of ZEBRA-associated Rp or oriLyt was corrected for the total level of Rp or oriLyt present in the corresponding input
sample. Panels A and B and panels C and D represent data from two separate ChIP experiments.
doi:10.1371/journal.ppat.1001054.g006
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PLoS Pathogens | www.plospathogens.org 10 August 2010 | Volume 6 | Issue 8 | e1001054Figure 7. ZEBRA RD mutants share a common defect in interacting in vivo with Biotinylated probes containing regions of oriLyt and
brlf1 promoter (Rp). The capacity of ZEBRA mutants to bind to the upstream region of oriLyt [BUR] (panel A), a short region of Rp [BRpS] (panel B)
and full length Rp [BRpL] (panel C) was compared. BZKO cells were transfected with expression vectors for the indicated forms of ZEBRA together
with Biotinylated oligomers containing one of these three regulatory regions. The Biotinylated probes were purified from cell lysates using avidin
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replication proteins enhanced the ability of wild type and mutant
forms of ZEBRA protein to associate with oriLyt in vivo. A 1.8-fold
increase in association with oriLyt was detected with wt ZEBRA;
2.2-fold with Z(S173A); 3-fold with Z(Y180E), and 4.24-fold with
Z(S167A/S173A) (Fig. 9C).
A compilation of several chromatin immunoprecipitation
experiments showed that replication defective ZEBRA mutants
weakly associated with oriLyt (Fig. S2A). Z(S173A) was the least
defective while Z(K188A) was the most impaired. For wild type
ZEBRA and three of the mutants, Z(S173A), Z(Y180E) and
Z(S167A/S173A), we demonstrated an increase in their associa-
tion with oriLyt as a result of overexpressing the EBV replication
proteins. The effect of replication proteins on association of
ZEBRA with oriLyt was greatest with the mutant Z(S167A/
S173A), 6.87-fold. Z(Y180E) precipitated 3 times more oriLyt in
the presence replication proteins; Z(S173A), 1.8-fold, and wild
type ZEBRA 1.6-fold (Fig. S2A). The two ZEBRA RD mutants
which were most defective in binding to oriLyt, namely Z(R187K)
and Z(K188A) were the least affected by replication proteins.
To investigate further the effect of replication proteins on
interaction of ZEBRA with oriLyt we transfected BZKO cells with
Biotin-conjugated oriLyt Full length (BOF) and expression vectors
encoding wild type and the RD ZEBRA mutants with and without
replication proteins. Cells were harvested 48 h after transfection;
ZEBRA bound to oriLyt was purified using avidin coated beads.
Both input and BoF-captured ZEBRA proteins were analyzed by
Western blot. The effect of replication proteins on binding of
ZEBRA to oriLyt was calculated after correcting for the amount of
ZEBRA present in the corresponding input samples. We found
that co-expression of the six core components of the replication
machinery enhanced binding of wt ZEBRA, Z(Y180E), Z(R187K)
and Z(S173A) to oriLyt by 2.1-, 6.0-, 16.4- and 5.0-fold,
respectively. In summary the ChIP and iBDAA experiments
demonstrate that the core components of the EBV replication
machinery augment the interaction between ZEBRA and oriLyt.
Replication proteins enhanced interaction of ZEBRA with
EBV early lytic cycle promoters
To determine whether the effects of replication proteins were
specific for ZEBRA’s association with oriLyt, we examined the
effect of replication proteins on association of ZEBRA with other
lytic viral regulatory sites by studying interaction of ZEBRA and
RD mutants with Rp and two other ZEBRA responsive
promoters, BZLF1p (Zp) and BMRF1p (EAp). Zp is auto-
stimulated by ZEBRA while BMRF1p is activated by synergy
between ZEBRA and Rta. Over-expression of the six EBV
replication proteins increased the relative amount of Rp, Zp and
BMRF1p DNA precipitated by wt ZEBRA, Z(S167A/S173A) and
Z(S173A) (Fig. S2B and Supplementary Table S1). The effect of
replication proteins on the amount of viral DNA pulled down by
Z(Y180E) was more pronounced on Rp (2.2-fold). The amount of
Z(Y180E) bound to Zp and BMRF1p was minimally enhanced by
replication factors, 1.3-fold and 1.25-fold, respectively. No
difference was detected by ChIP for the effect of replication
proteins on the relative binding capacity of Z(R187K) and
Z(K188A) to Rp. This could be attributed to the marked defect
in the DNA binding capacity of these two mutants or limitations in
the ChIP technique to detect small changes in association with a
particular site. Our results show that replication proteins enhance
the interaction of ZEBRA and the phosphorylation site mutants
with oriLyt, and with at least three transcription regulatory sites,
Rp, Zp and EAp.
Three replication proteins are sufficient to rescue the
functional defect in ZEBRA RD mutants
To delineate the contribution of each replication protein in
restoring lytic viral DNA synthesis, Z(S173A) was co-expressed
with different mixtures of replication proteins. In each mixture one
of the six components was omitted. After 48 h, DNA was purified
from BZKO cells and analyzed for its viral DNA content using
quantitative PCR (Fig. S1). Elimination of individual components
of the mixture of replication proteins led to several distinct
outcomes. Exclusion of BBLF2/3 had no significant effect.
Omission of BALF2 and BBLF4 reduced the efficacy of the
replication proteins complex to rescue replication by Z(S173A).
Eliminating BSLF1 or BMRF1 from the mixture of replication
proteins abolished its activity. In contrast, omitting the expression
vector of BALF5 augmented the capacity of the other five
replication proteins to restore viral replication by Z(S173A). These
results suggest that over-expression of different mixtures of
replication proteins can stimulate, inhibit or have no effect on
viral replication.
To select the minimum subset of replication proteins sufficient to
suppress the phenotype of these RD ZEBRA mutants, we examined
the effect of expressing the primase individually or together with
various combinations of replication proteins excluding the polymer-
ase (BALF5) that had been shown to be inhibitory (Fig. S1). After
48 h, transfected BZKO cells were analyzed by Western blot for the
level of the FR3 protein as a marker for late gene expression. While
co-expression of all six replication proteins with Z(S173A) induced
late gene expression to 33.4 and 35.4% that of wt ZEBRA (Fig. 10A
compare lane 3 to 4 and 13 to 14), addition of the primase alone had
no significant effect on the level of the FR3 protein as compared to
cells transfected with the S173A mutant in absence of RP. However,
combining the primase with either the viral single-stranded DNA
binding protein (BALF2) or the viral DNA polymerase processivity
factor (BMRF1) enhanced late gene expression to 21.8 and 27.2% of
wild type, respectively. A mixture containing all three proteins, the
primase, the ssDNA-binding protein and the DNA polymerase
processivity factor, restored late gene expression to 49.1%, a level
higher than that induced by all six replication proteins (Fig. 10A lane
17). Addition of the viral helicase and/or the primase associated
factor was either inhibitory or had no effect on the level of FR3.
To assess the effect of the different combinations of replication
proteins on viral replication, we purified DNA from the same
group of cells and analyzed it using quantitative PCR. The
findings obtained by qPCR were similar to those seen by analyzing
late gene expression. A mixture of the primase, the single-stranded
DNA binding protein and the DNA polymerase processivity factor
suppressed the defect in Z(S173A) and restored replication to
approximately 44% that of the level activated by the wild type
protein (Fig. 10A).
To determine if the same tripartite mixture of replication
proteins could complement the defect in viral genome amplifica-
tion observed in ZEBRA mutants in the DNA recognition domain,
we repeated the same experiment using Z(R187K). Addition of all
replication proteins induced viral replication 2.2-fold above that
beads. The amount of ZEBRA bound to each probe and the total amount of ZEBRA present in each lysate were assessed by western blot analysis.
Relative binding was calculated by comparing the amount of ZEBRA pulled down by the probe corrected for the total amount of ZEBRA detected in
input samples.
doi:10.1371/journal.ppat.1001054.g007
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DNA polymerase processivity factor together with Z(R187K) had
no effect on late gene expression or viral DNA synthesis (Fig. 10B).
However, addition of the single-stranded DNA binding protein to
this mixture resulted in the highest impact on viral genome
amplification, a 4.2-fold increase compared to replication induced
by Z(R187K) alone (Fig. 10B). Similar results were observed for
the effect of these three replication proteins on late gene expression
(Fig. 10B).
The capacity of BALF2, BMRF1 and BSLF1 to rescue viral
genome amplification by all five identified ZEBRA RD mutants
was examined. BZKO cells were transfected with expression
Figure 8. Over-expression of EBV replication proteins partially suppresses the phenotype of Z(S173A) and Z(R187K). A) Immunoblot
demonstrating the effect of EBV replication proteins on late gene expression in BZKO cells expressing Z(S173A), Z(Y180E), and Z(K188A). The
membrane was blotted with antibodies against the indicated viral proteins FR3, ZEBRA and EBNA1. B) Replication assay to measure the extent of viral
genome amplification induced by wt ZEBRA and the indicated ZEBRA mutants in the absence or presence of a mixture of expression vectors
encoding the six EBV replication proteins. C and D) Immunoblots of BZKO cell extracts transfected with empty vector or expression vectors encoding
wt ZEBRA or the indicated ZEBRA RD mutants with and without the six core EBV replication proteins. The membrane was blotted with antibodies
specific to FLAG tag, ZEBRA and FR3.
doi:10.1371/journal.ppat.1001054.g008
Figure 9. EBV replication proteins enhance association of ZEBRA with oriLyt. A) ChIP comparing the level of ZEBRA-bound oriLyt in the
absence and presence of replication proteins. Real time PCR was employed to detect the level of co-immunoprecipitated oriLyt using primers
complementary to the upstream region. B) Immunoprecipitation of ZEBRA proteins from BZKO cell extracts using the same conditions followed in
ChIP. C) A biological replicate experiment using chromatin immunoprecipitation of wt ZEBRA and the indicated ZEBRA mutants to study the effect of
expressing a mixture of EBV replication proteins on the interaction between ZEBRA and oriLyt. Fold association with EBV oriLyt DNA was corrected for
the amount of input oriLyt. D) Western blot analyses showing the amount of ZEBRA proteins either pulled down by biotinylated full length oriLyt
(BoF) (upper panel) or present in input samples (lower panel), in the absence and presence of replication proteins.
doi:10.1371/journal.ppat.1001054.g009
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PLoS Pathogens | www.plospathogens.org 14 August 2010 | Volume 6 | Issue 8 | e1001054Figure 10. Three replication proteins are sufficient to rescue the late gene expression defect in the ZEBRA RD mutants. (A)
Immunoblot of BZKO cell extracts expressing empty vector (CMV), wt ZEBRA (Z) or Z(S173A) in the absence and presence of various combinations of
replication proteins. The membrane was probed for FLAG-BALF2 (ssDNA-binding protein), M1 (DNA processivity factor), ZEBRA (Z) and FR3 (the viral
capsid antigen BFRF3). Relative late gene expression and viral genome amplification were calculated by setting the levels induced by wt ZEBRA as
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Z(R187K), Z(K188A) and wild type ZEBRA in the absence and
presence of plasmids encoding the tripartite mixture of replication
proteins. Cells were harvested at 48 h and 72 h and DNA was
purified. The amount of EBV lytic replication induced by each
condition was assessed by qPCR. At both time points, over-
expression of the three components of the replication machinery
enhanced activation of EBV lytic DNA replication by all five
replication defective mutants as well as wt ZEBRA (Fig. S3).
Our findings stress the importance of the primase, the DNA
polymerase processivity factor and the single-stranded DNA
binding protein on suppressing the effect of ZEBRA mutations
that render the protein incompetent to activate lytic DNA
replication.
The tripartite replication mixture enhanced ZEBRA
interaction with the upstream region of oriLyt
The upstream region of oriLyt encompasses four ZEBRA
binding sites that are essential for oriLyt replication. Therefore it
was important to assess directly the effect of the three replication
proteins that rescued the function of the RD mutants on the
capacity of ZEBRA to interact with the upstream region of oriLyt.
In an iBDA assay, we transfected BZKO cells with a biotinylated
upstream region of oriLyt (BUR) together with expression vectors
for wt ZEBRA or Z(S173A) in the absence and presence of the
tripartite replication mixture. BUR-bound ZEBRA was captured
on avidin coated beads and the amount of ZEBRA bound was
analyzed by western blot. We found that over-expression of the
primase, the ssDNA-binding protein and the polymerase associ-
ated factor resulted in a 2.5- to 3.7-fold increase in the amount of
ZEBRA that interacted with BUR (Fig. 10C). This finding
supports a role for the tripartite mixture of replication proteins in
lytic origin recognition by ZEBRA.
Expression of the tripartite mixture of BALF2, BMRF1 and
BSLF1 co-activate transcription of brlf1, the gene
encoding Rta, by ZEBRA mutants
The results presented in supplemental Fig. S2B show that over-
expression of replication proteins enhanced the capacity of wt
ZEBRA, the phosphorylation site mutants and Z(Y180E) to
interact with Rp, the BRLF1 promoter. The functional signifi-
cance of expressing this subset of replication proteins on
transcriptional activation of brlf1 by wt ZEBRA or mutant
ZEBRA was studied in BZKO cells. To maintain an equal
number of viral genome templates in each group, viral replication
was blocked by phosphonoacetic acid (PAA) and the cells were
harvested after 24 hours. Total RNA was purified and the level of
brlf1 transcript was assessed using quantitative RT-PCR. Fig. S4A
represents the average of two biological replicate experiments in
which each value is the mean of three distinct RT-PCR reactions.
As previously demonstrated in Fig. 2, expression of ZEBRA
replication defective mutants induced the synthesis of up to 2.4-
fold more brlf1 mRNA than did wt ZEBRA. Over-expression of
the tripartite mixture of replication proteins co-stimulated
synthesis of the brlf1 transcript to various levels depending on
the form of the ZEBRA protein being expressed. Replication
proteins had a modest effect on the capacity of wt ZEBRA,
Z(S173A) and Z(S167A/S173A) to activate transcription of brlf1
(1.3 to 1.5- fold). A significant 2.4-fold to 3.6-fold increase in the
level of the brlf1 transcript was detected when BALF2, BMRF1
and BSLF1 were co-expressed with each of the three DNA binding
domain ZEBRA mutants, Z(Y180E), Z(R187K) and Z(K188A).
These results show that despite the defect in activating DNA lytic
replication, all ZEBRA RD mutants were capable of activating
transcription to levels equal to or higher than that of wt ZEBRA.
In addition, replication proteins enhanced the capacity of wt
ZEBRA and ZEBRA RD mutants to activate transcription of brlf1.
This effect was more prominent when the BALF2-BMRF1-BSLF1
mixture was co-expressed with any of the three mutant forms of
ZEBRA proteins containing single point mutations in the DNA
recognition domain. The tripartite mixture of replication factors
also enhanced the level of Rta protein activated by wild-type and
mutant ZEBRA proteins. The enhancement was most marked for
RD mutants Z(Y180E) and Z(R187K) (Fig. S4B).
Discussion
In this study we provide evidence that a subset of virally
encoded replication proteins enhance origin recognition by
ZEBRA during lytic viral replication by promoting the capacity
of ZEBRA to bind to viral DNA. ZEBRA binds specifically to a set
of DNA sequences that are scattered throughout viral and cellular
genomes. The EBV origin of lytic replication, oriLyt, is recognized
by ZEBRA which also serves as a strong transcription activator by
binding to lytic gene promoters. The ability of ZEBRA to perform
two distinct functions in the same cell poses a biologically
important question, namely, how would a protein like ZEBRA
distinguish between a site that promotes transcription and another
one that triggers replication? We addressed this question by
characterizing a set of ZEBRA mutations that specifically
disrupted the protein’s ability to activate lytic viral replication
(Fig. 1). These mutations are not significantly impaired at
activating transcription and on most targets are enhanced as
transcription activators (Fig. 2, 3, S4A and S5).
A common defect observed among all five mutants was
reduced DNA binding activity. Impairment of the ZEBRA
mutants to interact with DNA was not specific to a particular
ZEBRA response element and was detected whether we studied
binding of ZEBRA to oriLyt or to promoters that regulate
expression Rta, ZEBRA and BMRF1 (Fig. 5, 7, S2B and Table
S1). However, the defect in DNA binding seemed to specifically
disrupt activation of viral replication without affecting transcrip-
tion (Fig. S5). This feature of the ZEBRA RD mutants allowed us
to investigate the effect of EBV replication proteins on the
interaction between ZEBRA and oriLyt and to correlate this
effect with activation of viral replication. Increasing the
concentration of all EBV replication proteins rescued the defect
in viral replication and enhanced the formation of the ZEBRA-
oriLyt complex (Fig. 8 and 9). A similar effect for replication
100%. (B) The effect of replication proteins on late gene expression and viral replication activated by Z(R187K). The membrane was blotted for BALF2
(A2) and BMRF1 (M1) simultaneously using a FLAG antibody. Expression of ZEBRA (Z) and FR3 was determined using specific antibodies. (C)
Interaction of ZEBRA with the upstream region of oriLyt was markedly enhanced when (S1) the viral primase (BSLF1), (A2) the ssDNA-binding protein
(BALF2) and (M1) the polymerase associated factor (BMRF1) were over-expressed. Panel (i) depicts the amount of ZEBRA captured by biotinylated
upstream region of oriLyt (BUR). Panel (ii) depicts ssDNA-binding protein and polymerase associated factor while panel (iii) portrays the total amount
of ZEBRA present in input samples. The ssDNA-binding protein and the polymerase associated factor were both detected using a FLAG monoclonal
antibody. Relative binding of ZEBRA to BUR was corrected for the corresponding amount of input protein. RPs, replication proteins; B2/3, the primase
associated factor (BBLF2/3), and B4, the helicase (BBLF4).
doi:10.1371/journal.ppat.1001054.g010
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is not an artifact caused by the mutations installed in ZEBRA or
due to failure of the RD mutants to activate expression of
replication proteins. Subtraction experiments indicated that
removal of the DNA polymerase (BALF5) from the mixture of
replication proteins enhanced DNA replication while removal of
expression vector encoding the viral primase (BSLF1) or the
polymerase processivity factor (BMRF1) was detrimental (Fig. 10
and Fig. S1). In a reconstruction experiment, three EBV
replication proteins were found to be sufficient to suppress the
defect in replication and DNA binding associated with the
ZEBRA RD mutants; these are the primase, the single-stranded
DNA binding protein and the DNA polymerase processivity
factor (Fig. 10 and Fig. S3). Expression of this tripartite
replication mixture increased the level of Rta (brlf1)t r a n s c r i p t
and protein (Fig. S4). Thus, replication proteins seem to co-
stimulate the capacity of ZEBRA to activate expression of Rta
and consequently expression of replication factors prior to viral
genome amplification. In summary, our findings support a model
(Fig. 11) in which replication proteins promote lytic viral DNA
synthesis in at least three different ways: i) replication proteins co-
stimulate the capacity of ZEBRA to express Rta and other early
lytic cycle products; ii) replication proteins augment the ability of
ZEBRA to interact tightly with oriLyt, and iii) replication
proteins comprise the EBV lytic replication machinery.
Strong DNA binding is a requirement for viral replication
ZEBRA RD mutants with compromised DNA binding activity
can be divided into two subclasses: the phosphorylation site
mutants, Z(S173A) and Z(S167A/S173A), and the basic domain
mutants, Z(Y180E), Z(R187K) and Z(K188A) [25,28]. The defect
in DNA binding was demonstrated using three different DNA
binding assays: EMSA, ChIP and in vivo biotin-conjugated DNA
affinity assay (iBDAA). Each of these assays addressed a different
aspect of the DNA binding activity of ZEBRA. EMSA compared
the capacity of the ZEBRA RD mutants to bind to individual
ZREs in vitro. Four ZREs were tested, three present in oriLyt
(ZRE1–3) and a fourth (ZIIIB) in Zp. The defect in binding to
these sites by the ZEBRA RD mutants was severe relative to the
wild type protein. However, examining the ability of the mutants
to associate with oriLyt in vivo using ChIP revealed a milder defect
(2- to 8-fold) (Fig. 6). This difference could be attributed to several
factors; for example, ZEBRA binds to ZREs present in oriLyt in a
cooperative manner [39], other viral proteins affect ZEBRA
association to oriLyt (Fig. 9), and formation of pre-replication foci
increases the local concentration of ZEBRA [40]. To directly
assess the level of ZEBRA protein bound to oriLyt or Rp, we
examined interaction of ZEBRA with biotinylated probes in
BZKO cells. Using this in vivo biotinylated DNA affinity assay
(iBDAA), we showed that all the mutants were impaired in their
capacity to associate with both the oriLyt and Rp probes (Fig. 7).
Figure 11. Proposed model for the role of BALF2, BMRF1 and BSLF1 in regulating viral replication. The model has several components:
1) ZEBRA activates Rta as a very early event of lytic cycle activation. 2) ZEBRA and Rta synergistically activate BALF2 and BMRF1. 3) Rta independently
activates BSLF1 (data not shown). 4) The three replication proteins enhance the capacity of ZEBRA to activate transcription of Rta via a feedback loop
(Fig. S4). 5) The three replication proteins enhance the interaction between ZEBRA and oriLyt (Fig. 9 and S2A).
doi:10.1371/journal.ppat.1001054.g011
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important correlations between strong interaction of ZEBRA with
oriLyt and its capacity to activate viral replication. These
correlations are: 1) all five ZEBRA mutants defective in activating
viral replication exhibited a 2- to 8-fold defect in interacting with
oriLyt (Fig. S2A). 2) The level of reduction in the DNA binding of
each mutant correlated with its defect in stimulating viral
replication (Fig. S5). 3) Replication proteins that enhanced
interaction of ZEBRA with oriLyt restored viral replication
(Fig. 9 and S2A). 4) At position S173, a mutation that disrupts
DNA binding, e.g. Z(S173A), also abolishes viral replication, while
another substitution that maintains DNA binding, e.g. Z(S173D),
has no effect on viral replication [25]. All together these
correlations point to the importance of strong interaction between
ZEBRA and oriLyt to stimulate viral replication.
Replication proteins play a role in origin recognition
Specific DNA binding by a protein that regulates different
processes is not sufficient to confer specificity; additional levels of
regulation likely play an important role beyond the initial step of
DNA recognition. Consistent with the notion that initial
recognition of the origin by the origin binding protein per se is
not sufficient to induce replication, in Saccharomyces cervisiae,
interaction with Cdc6p increased sequence-specific binding of
ORC to the origin by altering its structure [29]. Also, the herpes
simplex virus polymerase processivity factor (UL42) facilitated
loading of the origin binding protein (UL9) to single-stranded or
partially duplex DNA [41]. This study was done in vitro and the
effect of replication proteins on the process of replication was not
directly assessed in infected cells.
Here, we showed that expression of replication proteins
enhanced interaction of ZEBRA with both oriLyt and Rp. This
enhancement in binding is likely to have more impact on
replication than on transcription of brlf1 for the following reasons:
1) the ZEBRA RD mutants were fully competent to activate
transcription of Rta and other lytic products. 2) Replication, and
not transcription, was dependent on the capacity of ZEBRA to
strongly bind to the corresponding viral DNA regulatory sites. 3)
The replication proteins not only enhanced oriLyt recognition by
the ZEBRA RD mutants but also restored their capacity to
activate viral replication and late gene expression.
Over-expression of the tripartite mixture of replication factors
did not rescue viral replication by the ZEBRA RD mutants to wild
type level. This could be due to the presence of additional defects,
other than DNA binding, in the ZEBRA RD mutants.
Alternatively, over-expression of other viral or cellular proteins
might be necessary to completely suppress the phenotype of these
mutants in replication. However, a complete rescue of the mutants
might be technically challenging since it is unlikely that all the cells
will obtain and express the transfected plasmids.
Two findings suggest that replication proteins exert their effects
early, during the assembly of the pre-replication complex or in the
initial stages of replication rather than in extension. First, omission
of the viral DNA polymerase (BALF5) expression vector markedly
enhanced viral replication (Fig. S1). Second, addition of
phosphonoacetic acid (PAA), an inhibitor of the viral DNA
polymerase, had no effect on the ability of replication proteins to
enhance ZEBRA association with oriLyt (Fig. 9). This effect of
replication proteins is specific to three of the six replication
proteins and is unlikely to be due to over-expression. In other
EBV-infected cell lines, such as the Burkitt lymphoma derived cell
line HH514-16, replication proteins are expressed at much higher
levels than in transfected BZKO cells (Fig. 3A and [25]).
Origin recognition is a complex process that is regulated at
multiple levels. In addition to the role of replication proteins in
enhancing association of ZEBRA with oriLyt, other mechanisms
must also be involved. For example, interaction of BBLF2/3 with
ZBRK1 serves as a tethering point on oriLyt for other replication
proteins [19]. The involvement of multiple mechanisms in
regulation of origin recognition reflects the complexity of such
an initial but essential step for activation of EBV replication.
Replication proteins stimulate expression of Rta
At the initial stage of the EBV lytic cycle, stimulation of Rta
expression by ZEBRA is independent of the presence of any
replication proteins. As the lytic cycle proceeds into the early
phase, ZEBRA and Rta, solely or synergistically, activate
transcription of genes encoding the different components of the
replication machinery. Our data shows that expression of three
replication proteins, BALF2, BMRF1 and BSLF1 positively
modulate the capacity of ZEBRA to stimulate expression of Rta
(Fig. 2, S2B and S4). The co-stimulatory effect of this subset of
replication proteins on Rta expression is likely to be a secondary
event that occurs later during the pre-replicative phase of the lytic
cycle. Our findings suggest that replication proteins trigger a
positive feedback mechanism prior to viral replication that
increases the level of Rta and replication proteins (Fig. 11).
Upsurge in expression of replication proteins is likely to play a
significant role in origin recognition, assembly of the replication
complex and the process of viral DNA synthesis.
Evidence supporting the possible role of replication proteins in a
positive feedback loop comes from a recent report suggesting that
the DNA polymerase processivity factor, BMRF1, enhances the
capacity of ZEBRA to activate the BALF2 promoter [42]. BMRF1
has also been shown to modulate the ability of Sp1 and ZBP-89 to
activate the early viral BHLF1 promoter and the cellular gastrin
promoter [43,44]. The mechanism responsible for the transcrip-
tional co-activation function of BMRF1 is still unknown. It is
possible that the effect of replication proteins in augmenting the
capacity of ZEBRA to activate transcription is mediated by
BMRF1 only.
Models for the role of replication proteins in origin
recognition
The following models might account for the role of replication
proteins in origin recognition. First, ZEBRA interacts with sub-
complex(es) containing the three replication proteins, the primase,
the ssDNA-binding protein and the DNA polymerase processivity
factor, off DNA. This interaction results in the formation of a high
affinity quaternary origin recognition complex. Second, ZEBRA
binds independently to oriLyt and interacts with replication
proteins that are already tethered to oriLyt through other cellular
transcription factors, e.g. Sp1 and ZBRK1 [18,19,23]. The
formation of this network of protein-protein interactions with
multiple contacts among replication proteins, ZEBRA and oriLyt
is likely to have a synergistic effect on the stability of this protein-
DNA complex and to facilitate recruitment of other replication
proteins [45]. Third, formation of the ZEBRA-oriLyt complex
results in a specific DNA-protein architecture that functions as a
landing pad for the three replication proteins which in turn
augment and stabilize the interaction between ZEBRA and oriLyt.
One possible function for the three replication proteins is to
enhance the capacity of ZEBRA to occupy all the ZREs present in
oriLyt (Fig. 9D and Fig. 10C). ZEBRA-oriLyt complexes that are
not recognized by these three proteins are likely to become
unstable and will fail to assemble a functional replication complex.
These models do not yet account for the precise role of individual
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such as the ssDNA-binding protein, alters the origin binding
capacity of ZEBRA while the two other proteins are important in
subsequent events.
Based on our results, we propose that a tripartite mixture of
replication proteins plays a role in EBV lytic origin recognition.
This is a novel role for replication proteins. Additional
experiments will be necessary to investigate the mechanism(s) by
which each of these three replication proteins modulate the
binding activity of ZEBRA to oriLyt and other ZEBRA response
elements and enhance viral replication and transcription.
Materials and Methods
Plasmids
The plasmids pHD1013/Z, pHD1013/Z(S173A), pHD1013/
Z(R187K), pHD1013/Z(Y180E), pHD1013/Z(K188A), pHD1013/
Z(K188R), pHD1013/Z(F193E) and pHD1013/Z(K194A) were
prepared as described previously [28,46]. Expression vectors for the
viral open reading frames encoding BALF5, BBLF4, BBLF2/3 and
BSLF1 were a kind gift from Dr. Diane Hayward [4]. The full length
coding sequences for BALF2 and BMRF1 were amplified from EBV
genomes purified from HH514-16 cells by PCR. The amplified
fragments were cloned in pFLAG-CMV2 using EcoR1 and Xba1
restriction sites.
Cell culture and transfection
BZKO cells were previously described [1]. HKB5/B5 cells
represent an EBV negative subclone that was initially generated by
hybridizing HEK293 cells with the EBV positive cell line HH514-
16 [47]. All transient transfection experiments were performed in
25 cm
2 flasks using 3 mg of ZEBRA expression vector and 2 mgo f
each construct encoding a replication protein. The DMRIE-C
reagent (Invitrogen) was used for transfection according to the
manufacturer’s protocol.
Immunoblotting, immunoprecipitation and ChIP
Immunoblotting was performed as previously described [28].
The following antibodies were used: anti-ZEBRA, anti-FR3 and
anti-LR2 are polyclonal rabbit sera raised to TrpE-fusion proteins
expressed in E. coli. The anti-Rta antibody was generated by
expressing the C-terminal 320 a.a of Rta using the pET-expression
system. The fragment was purified on a nickel column and used
for rabbit immunization. The monoclonal antibody against
BMRF1 (EA-D) (R3.1) was a kind gift from G. Pearson. Anti-
FLAG is a mouse monoclonal antibody (Sigma). ChIP experi-
ments were performed as previously detailed [25]. Sequences for
the primers used are available upon request.
Northern and Southern blot analyses
RNA was purified from 8610
6 BZKO or HH514-16 cells using
RNeasy kits (Qiagen) according to the manufacturer’s protocol. All
RNA samples were treated with 30 U DNase1 (Qiagen). Twenty
micrograms of RNA was separated on 1% agarose gel and
transferred by capillarity to a Hybond N+ filter (Amersham). The
membrane was hybridized to two
32P-labeled probes detecting the
H1 component of RNase P (a loading control) and BALF2. The
probes were generated from a 370-bp NcoI-Pst1 fragment of
RNase P and full length BALF2 DNA using random primers.
DNA was isolated from 10
7 BZKO cells as detailed previously
[28]. Ten micrograms of DNA was digested with 40 units BamH1
(New England Biolabs) for 3 h at 37uC. DNA fragments were
separated by electrophoresis in a 0.8% agarose gel and transferred
to a Zeta probe GT genomic membrane (Bio-Rad). Formation of a
replication ladder was detected using a probe complementary to a
336-bp sequence in the unique Xho 1.9-kb sequence upstream of
the viral terminal repeats [34]. The template for the 336-bp probe
was generated by PCR using the following primers 59-CTCAC-
GAGCAGGTGG-39 and 59-CGCAGTCTTAGGTATCTGG-
39. An excised EBV BamH1 W fragment was used as a template
to generate a corresponding probe [48]. Radioactive probes were
synthesized using 10 units of the Klenow fragment of DNA
polymerase (New England Biolabs), [a-
32P]dCTP and 1 ng
random primers. The probes were purified using a Sephadex-
G50 column.
Reverse transcription and quantitative PCR
RNA samples were prepared 48 h after transfection of BZKO
cells. Phosphonoacetic acid (PAA) was added to inhibit viral
replication. RT-PCR was performed on 100 ng of total RNA
using reagents and instructions described in the manual for the
SuperScript One-Step RT-PCR with platinum Taq kit (Invitro-
gen). In reactions where the reverse transcriptase was omitted, 2
units of platinum Taq was added. Random hexamers or gene
specific primers were used to generate cDNA. A 131-bp fragment
was amplified by the BBLF4 primers; a 121-bp fragment by the
BSLF1 primers, and 211-bp by the BBLF2/3 primers. The
sequences for the primers used are available upon request.
Incorporation of Sybr green into DNA was detected using
Cepheid Smart Cycler II or a Bio-Rad MyiQ real time PCR
machines. Standard curves were generated using 10-fold serial
dilutions of expression vectors encoding each of the three open
reading frames. Quantitative PCR for detection of viral genome
amplification was previously described [25].
EMSA
Preparation of supernatants of HKB5/B5 cell extracts express-
ing wt ZEBRA or mutants as well as the DNA binding reactions
were previously described [28]. Super-shifts were performed using
BZ1, a monoclonal antibody against the dimerization domain of
ZEBRA. The percent probe shifted is calculated as previously
described [28,49].
Binding to Biotin-labeled oriLyt
Full length oriLyt was cloned into pBSKII+ from HH514-16
cells using primers containing EcoR1 and BamH1 sites 59-
GCGCGAATTCTGGGGTCTCTGTGTAATACTTTAAG-39
and 59-GCGCGGATCCGTTA ATAAGGAGCC GTCCTTA-
TTC-39. Biotin-labeled full length oriLyt (BoF) was prepared by
PCR using primers that were conjugated to biotin at their 59ends.
BZKO cells were co-transfected with 150 ng BoF and the
indicated expression vectors. Cells were harvested after 60 h and
re-suspended in lysis buffer containing 15 mM Tris-HCl pH 8.1,
167 mM NaCl, 1.2 mM EDTA, 3 mM MgCl2, 0.01% SDS and
1.1% Triton X-100. Cell extracts were briefly sonicated and
supernatants were collected. The amounts of total protein were
assessed using the Bradford reagent (Bio-Rad) and equalized.
ZEBRA bound to BoF was captured using Avidin coated beads.
The beads were washed and heated in SDS-PAGE sample buffer.
The amount of captured ZEBRA protein was determined using
Western blot analysis.
Supporting Information
Figure S1 Effect of excluding individual components from the
mixture of EBV replication proteins on stimulation of viral
replication by Z(S173A). Quantitative-PCR was used to examine
relative EBV genome amplification in BZKO cells. Cells were
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ZEBRA mutant Z(S173A). Where indicated, the two forms of
ZEBRA were expressed with all six replication proteins (RPs).
Alternatively, a single component of the replication machinery was
omitted and the other five proteins were co-expressed with
Z(S173A). After 48 h, the cells were harvested and the
concentration of viral DNA was measured using primers specific
to the upstream region of oriLyt. Relative genome amplification
was calculated by comparison to DNA amplification by wt
ZEBRA protein which was set at 100.
Found at: doi:10.1371/journal.ppat.1001054.s001 (0.21 MB
TIF)
Figure S2 Replication proteins augment the association of
ZEBRA with oriLyt and Rp. Compilation of data from multiple
ChIp experiments examining the capacity of ZEBRA RD mutants
to interact with oriLyt (A) or Rp (B) and the effect of replication
proteins (RPs) on these interactions. Quantitative PCR data
obtained from each ChIp experiment was initially corrected for
the amount of input DNA and then normalized to the amount of
oriLyt or Rp precipitated from cells transfected with empty vector.
The extent of binding of each ZEBRA RD mutant to DNA was
then normalized to DNA binding by wt ZEBRA in the absence of
replication proteins. The letter n represents the number of
biological replicates for each condition. If n was more than one,
the average binding capacity of each mutant was calculated based
on values obtained from biological replicates. Each real time PCR
value used in this analysis was an average of three technical
repeats.
Found at: doi:10.1371/journal.ppat.1001054.s002 (0.52 MB TIF)
Figure S3 Overexpression of BALF2, BMRF1 and BSLF1
partially restores the genome amplification defect of ZEBRA RD
mutants. The indicated expression vectors were transfected into
BZKO cells. MSA represents plasmids encoding BMRF1, BSLF1
and BALF2, respectively. After 48 h (panel A) and 72 h (panel B)
the cells were harvested and DNA was purified. Quantitative PCR
was performed to assess the extent of EBV genome amplification.
Primers specific to the oriLyt region were used to measure the
amount of viral DNA synthesized under each condition. The fold
change in the level of viral DNA activated by each ZEBRA RD
mutant in the absence and presence of the MSA mixture of
replication proteins was calculated and compared to wt ZEBRA.
Found at: doi:10.1371/journal.ppat.1001054.s003 (0.51 MB TIF)
Figure S4 Replication proteins induce a co-stimulatory effect on
expression of Rta. A) Quantitative PCR to determine changes in
the level of brlf1 transcript following expression of the indicated
forms of ZEBRA in the absence or presence of BALF2, BMRF1
and BSLF1. Viral replication was blocked by PAA. BZKO cells
were harvested after 24 hours. The figure represents the average
of two biological replicate experiments. B) Western blot analysis
for the level of Rta protein induced by wt ZEBRA or the indicated
ZEBRA mutants in the absence and presence of the tripartite
mixture of replication proteins. MSA represents plasmids encoding
BMRF1, BSLF1 and BALF2, respectively.
Found at: doi:10.1371/journal.ppat.1001054.s004 (0.49 MB TIF)
Figure S5 Comparison between the capacity of ZEBRA to bind
to Rp and oriLyt with its ability to activate transcription of Rta
and DNA replication. A compilation of several experiments
already presented in the manuscript. Data representing activation
of the brlf1 (Rta) transcript is the average of three experiments
presented in Fig. 2 and S4. Association of ZEBRA with Rp or
oriLyt was presented in Fig. S2A and 2B, respectively. Quanti-
tative PCR determining the extent of viral genome amplification
was acquired from Fig. S3A. Together the data demonstrates that
the defect in DNA binding associated with the ZEBRA RD
mutants has no effect on transcription but has adverse effects on
replication.
Found at: doi:10.1371/journal.ppat.1001054.s005 (1.05 MB TIF)
Table S1 Summary of chromatin immunoprecipitation exper-
iments
Found at: doi:10.1371/journal.ppat.1001054.s006 (0.03 MB
DOC)
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